Details of the Drug | DrugMAP

General Information of Drug (ID: DMLD8DF)

Drug Name

MK-1942

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 2	[1]
Depression	6A70-6A7Z	Phase 2	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

TTD ID: DDAH09

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT05602727) A Phase 2a/2b Randomized, Placebo-Controlled Clinical Study To Evaluate The Safety And Efficacy Of MK-1942 As Adjunctive Therapy In Participants With Mild To Moderate Alzheimer's Disease Dementia. U.S.National Institutes of Health.
2	ClinicalTrials.gov (NCT04663321) A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression. U.S.National Institutes of Health.